Yi Liu

Johnson & Johnson Pharmaceutical Research and Development, Spring House, Pennsylvania, Saarbrücken, PA, United States 
ion channels, pain
"Yi Liu"
Mean distance: 16.9 (cluster 32)
Cross-listing: Chemistry Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Parsons WH, Calvo RR, Cheung W, et al. (2015) Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep). Journal of Medicinal Chemistry. 58: 3859-74
Finley MF, Lubin ML, Neeper MP, et al. (2010) An integrated multiassay approach to the discovery of small-molecule N-type voltage-gated calcium channel antagonists. Assay and Drug Development Technologies. 8: 685-94
Parker MH, Smith-Swintosky VL, McComsey DF, et al. (2009) Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies. Journal of Medicinal Chemistry. 52: 7528-36
Mathes C, Friis S, Finley M, et al. (2009) QPatch: the missing link between HTS and ion channel drug discovery. Combinatorial Chemistry & High Throughput Screening. 12: 78-95
See more...